2018
DOI: 10.1007/s13205-018-1368-y
|View full text |Cite
|
Sign up to set email alerts
|

Futuristic biosensors for cardiac health care: an artificial intelligence approach

Abstract: Biosensor-based devices are pioneering in the modern biomedical applications and will be the future of cardiac health care. The coupling of artificial intelligence (AI) for cardiac monitoring-based biosensors for the point of care (POC) diagnostics is prominently reviewed here. This review deciphers the most significant machine-learning algorithms for the futuristic biosensors along with the internet of things, computational techniques and microchip-based essential cardiac biomarkers for real-time health monit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
42
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 84 publications
(42 citation statements)
references
References 70 publications
0
42
0
Order By: Relevance
“…The vast majority of biotechnologically employed protein‐based scaffolds including many VNPs do not allow significant, well‐controlled changes of their overall size and shape, although this is sought after especially for medical precision treatments and next‐generation sensors. Respective applications comprise for example, shape‐controlled intracellular enzyme or antibody delivery (e.g., Eiben et al, ; Wen & Steinmetz, , and references therein), or bionanochip technology as discussed for portable devices and point‐of‐care health monitoring (Vashistha, Dangi, Kumar, Chhabra, & Shukla, ). There is, however, a subset of the protein‐based scaffolds with a unique potential to satisfy even immodest wishes for a multivalent nanocarrier system with many selectively addressable anchoring sites and readily adaptable shapes: platforms with integral nucleic acids defining the final scaffold dimensions precisely.…”
Section: Introductionmentioning
confidence: 99%
“…The vast majority of biotechnologically employed protein‐based scaffolds including many VNPs do not allow significant, well‐controlled changes of their overall size and shape, although this is sought after especially for medical precision treatments and next‐generation sensors. Respective applications comprise for example, shape‐controlled intracellular enzyme or antibody delivery (e.g., Eiben et al, ; Wen & Steinmetz, , and references therein), or bionanochip technology as discussed for portable devices and point‐of‐care health monitoring (Vashistha, Dangi, Kumar, Chhabra, & Shukla, ). There is, however, a subset of the protein‐based scaffolds with a unique potential to satisfy even immodest wishes for a multivalent nanocarrier system with many selectively addressable anchoring sites and readily adaptable shapes: platforms with integral nucleic acids defining the final scaffold dimensions precisely.…”
Section: Introductionmentioning
confidence: 99%
“…Last but not least, biosensors are likely to enter a new stage by coupling with artificial intelligence (AI). AI biosensors and their future for healthcare application have been recently reviewed by Vashistha, Dangi, Kumar, Chhabra, and Shukla (2018) and Jin, Liu, Xu, Su, and Zhang (2020). This new concept also holds great potential to promote the surveillance and control of Salmonella for the food supply system.…”
Section: Recent Trends In Biosensor Development For Detection Of Salmmentioning
confidence: 99%
“…), magnetic (paramagnetic, supermagnetic), electrochemical (single walled Carbon nanotubes, Gold NPs modified on screen printed carbon electrodes, Au NP based graphite epoxy composite, Platinum NP coated nanoporous film et.) for detection of wide range of pathogenic bacteria such as Salmonella, S. aureus, B. anthracis [95].…”
Section: Conventional Biosensorsmentioning
confidence: 99%